# Contineum Therapeutics, Inc.: Form 8-K, filed Apr 30, 2026

- Company: [Contineum Therapeutics, Inc.](/companies/ctnm.md) (CIK 1855175)
- Form: 8-K
- Filed: 2026-04-30
- Accepted by EDGAR: Apr 30, 2026, 20:07 ET
- Period: 2026-04-30
- Accession: 0001628280-26-028876
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1855175/000162828026028876/ctnm-20260430.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1855175/000162828026028876/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1855175/000162828026028876/ctnm-20260430.htm

Filed Apr 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-028876. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.